ISO 28399:2021 – Dentistry — External Tooth Bleaching Products

Specifications and test methods for external tooth bleaching products used in dentistry

Overview of External Tooth Bleaching Standards

ISO 28399:2021 establishes the safety and performance requirements for externally applied tooth bleaching products used in dentistry. This third edition revises previous versions to incorporate updated safety data on hydrogen peroxide and carbamide peroxide concentrations, enhanced cytotoxicity testing protocols using three-dimensional oral tissue models rather than monolayer cell cultures, and clearer labeling requirements for patient safety. The standard applies to both professionally dispensed and over-the-counter bleaching products, covering gels, strips, paint-on formulations, and pre-filled tray systems. The clinical mechanism of tooth bleaching involves the diffusion of hydrogen peroxide through the enamel and dentin, where it decomposes into free radicals that oxidize long-chain organic chromophore molecules into smaller, less colored compounds. Understanding this diffusion chemistry is essential for engineers designing delivery systems that maximize peroxide penetration while minimizing pulpal irritation.

ISO 28399 distinguishes between three regulatory categories based on hydrogen peroxide equivalent concentration: professional in-office use only (6-16% H₂O₂), dentist-prescribed home use (0.1-6% H₂O₂), and general sale over-the-counter products (≤ 0.1% H₂O₂). Each category has distinct safety testing, clinical evidence, and labeling requirements that manufacturers must satisfy before market approval.

Chemical Composition and Concentration Limits

The standard specifies maximum hydrogen peroxide equivalent concentration of 16% for professional in-office use, based on clinical evidence that higher concentrations provide no additional whitening benefit but significantly increase the risk of pulpal inflammation and gingival chemical burns. For carbamide peroxide formulations, which decompose into hydrogen peroxide and urea upon contact with saliva, the equivalent hydrogen peroxide content is calculated as approximately one-third of the carbamide peroxide concentration by weight. Products must maintain pH between 5.5 and 8.0 throughout their labeled shelf life, as pH below 5.5 can cause enamel demineralization (the critical pH for hydroxyapatite dissolution), while pH above 8.0 accelerates peroxide decomposition and reduces shelf stability. The standard also specifies limits for heavy metal contaminants: arsenic ≤ 1 ppm, lead ≤ 5 ppm, and mercury ≤ 1 ppm, as these metals catalyze peroxide decomposition and may accumulate in dental tissues.

Product Category Max H₂O₂ Equivalent pH Range Clinical Supervision Min. Clinical Evidence
Professional in-office 16% 5.5-8.0 Dentist must be present 2 controlled clinical trials
Dentist-prescribed home 6% (10% CP) 5.5-7.5 Prescription and custom tray 1 controlled clinical trial
Over-the-counter 0.1% 6.0-7.5 None required Safety dossier only
Whitening strips 10% per strip 5.5-7.0 Varies by jurisdiction Per regulatory class
The 6% hydrogen peroxide threshold for home-use products is grounded in extensive clinical evidence showing that this concentration provides effective shade improvement of 4-8 Vita shade guide units over 14 days of overnight treatment (6-8 hours per night), with gingival irritation rates below 15% and tooth sensitivity below 30% when used with properly fitted custom trays.

Safety Testing Requirements and Biocompatibility Evaluation

ISO 28399 mandates a comprehensive biocompatibility testing program. Cytotoxicity testing per ISO 10993-5 must be conducted using three-dimensional reconstructed human oral epithelium models (such as EpiOral or similar validated tissue constructs) rather than monolayer cell cultures, as the latter overestimate toxicity by exposing all cells directly to the test material without the protective barrier effect of stratified epithelium. Oral mucosal irritation testing follows the ISO 10993-10 rabbit mucosal irritation model with a 4-hour contact period and 72-hour observation. Enamel surface effects must be characterized by measuring microhardness (Knoop or Vickers) before and after an accelerated bleaching protocol equivalent to 28 clinical days; the allowable reduction in enamel microhardness is limited to 25%. For products containing peroxides above 6%, genotoxicity screening using the Ames bacterial reverse mutation test (ISO 10993-3) and an in vitro micronucleus test are required to rule out DNA damage potential at clinically relevant exposure concentrations.

Prolonged or repeated exposure to high-concentration bleaching agents can cause transient tooth sensitivity (reported in 15-65% of patients depending on concentration and application protocol) and mild to moderate gingival irritation. Clinical evidence shows that products incorporating potassium nitrate (3-5%) as a desensitizing agent and sodium fluoride (0.2-0.5%) for remineralization support significantly reduce sensitivity incidence by 40-60% while maintaining whitening efficacy equivalent to formulations without desensitizers.

Engineering Design Insights for Bleaching Product Development

Formulation engineers must carefully balance multiple competing performance requirements when developing tooth bleaching products. The gel rheology must be shear-thinning (viscosity decreasing from approximately 50,000-100,000 cP at rest to 5,000-10,000 cP under application shear) to ensure easy dispensing from syringes while maintaining stable positioning within the dental tray. Carbopol polymers (cross-linked polyacrylic acid) at 0.5-2.0% concentration provide the optimal rheological profile and are compatible with peroxide chemistry if properly neutralized with triethanolamine or sodium hydroxide to pH 6.0-7.0. The addition of 0.1-0.5% sodium fluoride serves dual purposes: it promotes enamel remineralization and inhibits caries formation during the bleaching regimen. Packaging material selection is critical — opaque high-density polyethylene (HDPE) or polypropylene syringes with fluorinated inner surface treatment are required to prevent peroxide diffusion through the container walls and to avoid metal-catalyzed decomposition that occurs with aluminum or tin-plated packaging materials.

Never formulate tooth bleaching products in contact with any metal container or implement. Peroxides catalyze the oxidation of metal ions — particularly iron, copper, and manganese — leading to rapid exothermic decomposition that can pressurize containers and create a fire or explosion hazard. Only approved peroxide-compatible polymers (HDPE, PP, PTFE) or specially treated glass packaging should be used for all manufacturing, storage, and dispensing steps.

FAQ

Q: Can ISO 28399-certified bleaching products be used on dental restorations?
A: Bleaching agents primarily affect natural tooth structure by oxidizing organic chromophores within the enamel and dentin matrix. Composite resin restorations, ceramic crowns, and porcelain veneers do not lighten significantly. Post-bleaching color matching (waiting 2-4 weeks for tooth color stabilization) is essential before fabricating replacement restorations to avoid mismatch.
Q: What is the minimum effective treatment duration for home bleaching?
A: For 10-16% carbamide peroxide (≈3.3-5.3% H₂O₂), overnight application (6-8 hours) for 14 consecutive days is the clinical standard validated by multiple randomized controlled trials. Shorter daily application times or fewer treatment days result in proportionally less shade improvement.
Q: What is the typical shelf life of peroxide-based bleaching products?
A: Most peroxide gels maintain ≥ 90% of labeled potency for 12-24 months when stored at 2-25°C in original sealed packaging. Refrigeration at 2-8°C extends stability to 24-36 months. Products must include expiration dating based on real-time stability testing conducted at 25°C/60% RH per ICH Q1A guidelines.
Q: How does the standard address tooth sensitivity management?
A: The standard requires manufacturers to include specific instructions for managing sensitivity, such as reducing application time, using every-other-day application, or discontinuing use. Products marketed with desensitizing agents must provide clinical evidence of their efficacy in reducing sensitivity compared to equivalent formulations without desensitizers.

Leave a Reply

Your email address will not be published. Required fields are marked *